Cited by 4,051Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J.-F., Bruni, A. C., Montesi, M. P., Sorbi, S., Rainero, I., Pinessi, L., Nee, L., Chumakov, I., Pollen, D., Brookes, A., Sanseau, P., Polinsky, R. J., Wasco, W., Da Silva, H. A. R., Haines, J. L., Pericak-Vance, M. A., Tanzi, R. E., Roses, A. D., Fraser, P. E., Rommens, J. M., St George-Hyslop, P. H.·1995·Nature

DOI 10.1038/375754a0

Open this paper in CoChat — free account

Abstract

Some cases of Alzheimer's disease are inherited as an autosomal dominant trait. Genetic linkage studies have mapped a locus (AD3) associated with susceptibility to a very aggressive form of Alzheimer's disease to chromosome 14q24.3. We have defined a minimal cosegregating region containing the AD3 gene, and isolated at least 19 different transcripts encoded within this region. One of these transcripts (S182) corresponds to a novel gene whose product is predicted to contain multiple transmembrane domains and resembles an integral membrane protein. Five different missense mutations have been found that cosegregate with early-onset familial Alzheimer's disease. Because these changes occurred in conserved domains of this gene, and are not present in normal controls, they are likely to be causative of AD3.

Integrity signals

Registry

Crossref · 10.1038/375754a0

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Basic local alignment search tool
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669
A simple method for displaying the hydropathic character of a protein
Kyte, J., & Doolittle, R. F. (1982) · Journal of Molecular Biology · doi:10.1016/0022-2836(82)90515-0 · Cited by 22,927
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Self-citation
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Self-citation
Identification of the Cystic Fibrosis Gene: Genetic Analysis
Kerem, B.-S., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M., & Tsui, L.-C. (1989) · Science · doi:10.1126/science.2570460 · Cited by 4,142
Self-citation
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Self-citation
The 1993–94 Généthon human genetic linkage map
Gyapay, G., Morissette, J., Alain Vignal, A., Dib, C., Fizames, C., Millasseau, P., Marc, S., Bernardi, G., Lathrop, M. G., & Weissenbach, J. (1994) · Nature Genetics · doi:10.1038/ng0694supp-246 · Cited by 1,835
Structural features in eukaryotic mRNAs that modulate the initiation of translation.
Kozak, M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54860-2 · Cited by 1,826
A second-generation linkage map of the human genome
Weissenbach, J., Gyapay, G., Dib, C., Alain Vignal, A., Morissette, J., Millasseau, P., Vaysseix, G., & Lathrop, M. G. (1992) · Nature · doi:10.1038/359794a0 · Cited by 1,672

Show all 48 references

Research works printed but not linked: 8

Foncin, J.-F. et al. Rev. Neurol. 141, 194–202 (1985).
Bergamini, L. et al. Acta neurol. 13, 534–538 (1991).
Cruts, M. et al. Neurobiol Aging 15, S129 (1994).
Saleeba, J. A. & Cotton, R. G. Meth. Enzym. 217, 285–295 (1993).
Liu, Q. & Sommer, S. S. BioTechniques 18, 470–476 (1995).
Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. molec. Biol. 215, 403–410 (1990). · DOI · Paper page
Schellenberg, G. D. et al. Am. J. hum. Genet. 53, 619–628 (1993).
Kosik, K. & Greenberg, S. M. in Alzheimer Disease (eds Terry, R. D., Katzman, R. & Bick, K. L.) 335–344 (Raven, New York, 1994).

Sorted by citations

Items 701–800 of 1,049

Alzheimer’s disease due to loss of function: A new synthesis of the available data
Kepp, K. P. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.06.004 · Cited by 123
Characterization of human presenilin 1 using N‐terminal specific monoclonal antibodies: Evidence that Alzheimer mutations affect proteolytic processing
Mercken, M. H., Takahashi, H., Honda, T., Sato, K., Murayama, M., Nakazato, Y., Noguchi, K., Imahori, K., & Takashima, A. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00608-4 · Cited by 124
A Role for Presenilins in Autophagy Revisited: Normal Acidification of Lysosomes in Cells Lacking PSEN1 and PSEN2
Zhang, X., Garbett, K., Veeraraghavalu, K., Wilburn, B., Gilmore, R., Mirnics, K., & Sisodia, S. S. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0556-12.2012 · Cited by 122
Learning by Failing: Ideas and Concepts to Tackle γ-Secretases in Alzheimer's Disease and Beyond
De Strooper, B., & Chávez Gutiérrez, L. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124309 · Cited by 119
Nontranscriptional Role of Hif-1α in Activation of γ-Secretase and Notch Signaling in Breast Cancer
Villa, J. C., Chiu, D., Brandes, A., Escorcia, F. E., Villa, C. H., Maguire, W. F., Hu, C., de Stanchina, E., Simon, M. C., Sisodia, S. S., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.028 · Cited by 124
Vascular endothelial growth factor gene variability is associated with increased risk for AD
Bo, R. D., Scarlato, M., Ghezzi, S., Boneschi, F. M., Fenoglio, C., Galbiati, S., Virgilio, R., Galimberti, D., Galimberti, G., Crimi, M., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20390 · Cited by 123
Early-infantile galactosialidosis: Prenatal presentation and postnatal follow-up
Patel, M. S., Callahan, J. W., Zhang, S., Chan, A. K. J., Unger, S., Levin, A. V., Skomorowski, M., Feigenbaum, A. S. J., O’Brien, K., Hellmann, J., et al. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990702)85:1 · Cited by 45
Interaction of Presenilins with the Filamin Family of Actin-Binding Proteins
Zhang, W., Han, S. W., McKeel, D. W., Goate, A., & Wu, J. Y. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-03-00914.1998 · Cited by 123
Phosphodiesterase-4 (PDE4) Molecular Pharmacology and Alzheimer's Disease
Gurney, M. E., D'Amato, E. C., & Burgin, A. B. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0309-7 · Cited by 121
Forebrain degeneration and ventricle enlargement caused by double knockout of Alzheimer's presenilin-1 and presenilin-2
Feng, R., Wang, H., Wang, J., Shrom, D., Zeng, X., & Tsien, J. Z. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402733101 · Cited by 123
A Novel Presenilin‐2 Splice Variant in Human Alzheimer's Disease Brain Tissue
Sato, N., Hori, O., Yamaguchi, A., Lambert, J., Chartier‐Harlin, M., Robinson, P. A., Delacourte, A., Schmidt, A. M., Furuyama, T., Imaizumi, K., et al. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722498.x · Cited by 122
Increased Production of β-Amyloid and Vulnerability to Endoplasmic Reticulum Stress by an Aberrant Spliced Form of Presenilin 2
Sato, N., Imaizumi, K., Manabe, T., Taniguchi, M., Hitomi, J., Katayama, T., Yoneda, T., Morihara, T., Yasuda, Y., Takagi, T., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006886200 · Cited by 121
Self-citation
Diverse role of LDL receptor-related protein in the clearance of proteases and in signaling
Strickland, D. K., & Ranganathan, S. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00330.x · Cited by 126
Circulating Biomarkers of Cognitive Decline and Dementia
Solfrizzi, V., D'Introno, A., Colacicco, A. M., Capurso, C., Todarello, O., Pellicani, V., Capurso, S. A., Pietrarossa, G., Santamato, V., Capurso, A., et al. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.06.015 · Cited by 120
Genetic diagnosis and prognosis of Alzheimer’s disease: challenges and opportunities
Reitz, C. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1002469 · Cited by 125
Cortical Odor Processing in Health and Disease
Wilson, D. A., Xu, W., Sadrian, B., Courtiol, E., Cohen, Y., & Barnes, D. C. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63350-7.00011-5 · Cited by 129
Assembly, Maturation, and Trafficking of the γ-Secretase Complex in Alzheimers Disease
Dries, D. R., & Yu, G. (2008) · Current Alzheimer Research · doi:10.2174/156720508783954695 · Cited by 126
Age-independent and age-related deficits in visuospatial learning, sleep–wake states, thermoregulation and motor activity in PDAPP mice
Huitrón‐Reséndiz, S., Sánchez-Alavez, M., Gallegos, R. A., Berg, G. I., Crawford, E. F., Giacchino, J. L., Games, D., Henriksen, S. J., & Criado, J. R. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03373-x · Cited by 122
Beta-Secretase: Structure, Function, and Evolution
Venugopal, C., Demos, C., Rao, K. S. J., Pappolla, M. A., & Sambamurti, K. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708784936626 · Cited by 125
Therapeutic role of sirtuins in neurodegenerative disease
Outeiro, T. F., Marques, O., & Kazantsev, A. G. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.02.010 · Cited by 122
The Role of PICALM in Alzheimer’s Disease
Xu, W., Tan, L., & Yu, J. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8878-3 · Cited by 124
Induced Pluripotent Stem Cells from Familial Alzheimer's Disease Patients Differentiate into Mature Neurons with Amyloidogenic Properties
Mahairaki, V., Ryu, J., Peters, A., Chang, Q., Li, T., Park, T. S., Burridge, P. W., Talbot, C. C., Asnaghi, L., Martin, L. J., et al. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0511 · Cited by 120
Role of Epigenetics in Alzheimer ‘S and Parkinson‘S Disease
Kwok, J. B. (2010) · Epigenomics · doi:10.2217/epi.10.43 · Cited by 124
Diabetes Mellitus Induces Alzheimer’s Disease Pathology: Histopathological Evidence from Animal Models
Kimura, N. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040503 · Cited by 120
Mitochondrial Ca2+ Signaling in Health, Disease and Therapy
Modesti, L., Danese, A., Vitto, V. A. M., Ramaccini, D., Aguiari, G., Gafà, R., Lanza, G., Giorgi, C., & Pinton, P. (2021) · Cells · doi:10.3390/cells10061317 · Cited by 123
Insights into T‐cell dysfunction in Alzheimer's disease
Dai, L., & Shen, Y. (2021) · Aging Cell · doi:10.1111/acel.13511 · Cited by 123
New clues to Alzheimer's disease: Unraveling the roles of amyloid and tau
Yanker, B. A. (1996) · Nature Medicine · doi:10.1038/nm0896-850 · Cited by 120
Haplotypes extending across ACE are associated with Alzheimer's disease
Kehoe, P. G. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg094 · Cited by 120
Notch Receptors, Partners and Regulators: From Conserved Domains to Powerful Functions
Egan, S. E., St-Pierre, B., & Leow, C. C. (1998) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-80481-6_11 · Cited by 122
Intramembrane Proteolysis
Wolfe, M. S. (2009) · Chemical Reviews · doi:10.1021/cr8004197 · Cited by 120
Interleukin-1 and the Immunogenetics of Alzheimer Disease
Mrak, R. E., & Griffin, W. S. T. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.6.471 · Cited by 118
Accumulation of NEDD8 in neuronal and glial inclusions of neurodegenerative disorders
Mori, F., Nishie, M., Piao, Y., Kito, K., Kamitani, T., Takahashi, H., & Wakabayashi, K. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00603.x · Cited by 120
Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls
Simón‐Sánchez, J., & Singleton, A. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn096 · Cited by 118
Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years
Mondadori, C. R. A., Buchmann, A., Mustovic, H., Schmidt, C. F., Boesiger, P., Nitsch, R. M., Höck, C., Streffer, J. R., & Henke, K. (2006) · Brain · doi:10.1093/brain/awl266 · Cited by 121
Expression of human β‐secretase in the mouse brain increases the steady‐state level of β‐amyloid
Bodendorf, U., Danner, S., Fischer, F., Stefani, M., Sturchler, C., Wiederhold, K., Staufenbiel, M., & Paganetti, P. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2002.00770.x · Cited by 123
Increased Apoptosis Arising from Increased Expression of the Alzheimer's Disease–associated Presenilin-2 Mutation (N141I)
Janicki, S. M., & Monteiro, M. J. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.2.485 · Cited by 118
Dissociation between the Processivity and Total Activity of γ-Secretase: Implications for the Mechanism of Alzheimer's Disease-Causing Presenilin Mutations
Quintero-Monzon, O., Martin, M. M., Fernandez, M. A., Cappello, C. A., Krzysiak, A. J., Osenkowski, P., & Wolfe, M. S. (2011) · Biochemistry · doi:10.1021/bi2007146 · Cited by 118
Phosphorylation of Tau at S422 is enhanced by Aβ in TauPS2APP triple transgenic mice
Grueninger, F., Bohrmann, B., Czech, C., Ballard, T. M., Frey, J. R., Weidensteiner, C., von Kienlin, M., & Ozmen, L. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.09.004 · Cited by 117
SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer's disease risk
Reitz, C., Tokuhiro, S., Clark, L. N., Conrad, C., Vonsattel, J., Hazrati, L., Palotás, A., Lantigua, R., Medrano, M. A., Jiménez‐Velázquez, I. Z., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22308 · Cited by 120
Self-citation
Endoplasmic reticulum stress response in yeast and humans
Wu, H., Ng, B. S. H., & Thibault, G. (2014) · Bioscience Reports · doi:10.1042/bsr20140058 · Cited by 126
Structure and Function of the γ-Secretase Complex
Wolfe, M. S. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00401 · Cited by 124
cDNA cloning and chromosome mapping of the human Fe65 gene: interaction of the conserved cytoplasmic domains of the human beta-amyloid precursor protein and its homologues with the mouse Fe65 protein
Bressler, S. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.10.1589 · Cited by 117
Familial Alzheimer’s disease mutations in PSEN1 lead to premature human stem cell neurogenesis
Arber, C., Lovejoy, C., Harris, L., Willumsen, N., Alatza, A., Casey, J. M., Lines, G., Kerins, C., Mueller, A. K., Zetterberg, H., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108615 · Cited by 116
Alzheimer's Disease Mechanisms and Emerging Roads to Novel Therapeutics
Sala Frigerio, C., & De Strooper, B. (2016) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-070815-014015 · Cited by 116
Autophagosome dynamics in neurodegeneration at a glance
Wong, Y. C., & Holzbaur, E. L. F. (2015) · Journal of Cell Science · doi:10.1242/jcs.161216 · Cited by 117
PRECISION MEDICINE - THE GOLDEN GATE FOR DETECTION, TREATMENT AND PREVENTION OF ALZHEIMER’S DISEASE
Hampel, H. J., O’Bryant, S. E., Castrillo, J. I., Ritchie, C. W., Rojkova, K., Broich, K., Benda, N., Nisticò, R., Frank, R., Dubois, B., et al. (2016) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2016.112 · Cited by 117
Genetics of neurodegenerative diseases: an overview
Pihlstrøm, L., Wiethoff, S., & Houlden, H. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802395-2.00022-5 · Cited by 120
Curcumin mediates presenilin-1 activity to reduce β-amyloid production in a model of Alzheimer’s disease
Zhang, X., Hongmei, Z., Lu, S. Q., & Li, Y. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70629-6 · Cited by 116
Alzheimer's disease: β‐Amyloid protein and tau
Morishima‐Kawashima, M., & Ihara, Y. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10355 · Cited by 118
Clinical and Neuropathological Features of the Arctic APP Gene Mutation Causing Early-Onset Alzheimer Disease
Basun, H., Bogdanovic, N., Ingelsson, M., Almkvist, O., Näslund, J., Axelman, K., Bird, T. D., Nochlin, D., Schellenberg, G. D., Wahlund, L.-O., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.4.499 · Cited by 115
Early Onset of Hypersynchronous Network Activity and Expression of a Marker of Chronic Seizures in the Tg2576 Mouse Model of Alzheimer’s Disease
Bezzina, C., Verret, L., Juan, C., Remaud, J., Halley, H., Rampon, C., & Dahan, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119910 · Cited by 121
Calorie restriction ameliorates neurodegenerative phenotypes in forebrain-specific presenilin-1 and presenilin-2 double knockout mice
Wu, P., Shen, Q., Dong, S., Xu, Z., Tsien, J. Z., & Hu, Y. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.028 · Cited by 118
β-Amyloid Modulation of Synaptic Transmission and Plasticity
Venkitaramani, D. V., Chin, J., Netzer, W. J., Gouras, G. K., Lesné, S., Malinow, R., & Lombroso, P. J. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3478-07.2007 · Cited by 118
Fidelity of G protein β-subunit association by the G protein γ-subunit-like domains of RGS6, RGS7, and RGS11
Snow, B. E., Betts, L., Mangion, J., Sondek, J., & Siderovski, D. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6489 · Cited by 118
Epigenetics: A novel therapeutic approach for the treatment of Alzheimer's disease
Adwan, L. I., & Zawia, N. H. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.03.010 · Cited by 118
The neuritic plaque facilitates pathological conversion of tau in an Alzheimer’s disease mouse model
Li, T., Braunstein, K. E., Zhang, J., Lau, A., Sibener, L., Deeble, C., & Wong, P. C. (2016) · Nature Communications · doi:10.1038/ncomms12082 · Cited by 114
Endocytic uptake of monomeric amyloid-β peptides is clathrin- and dynamin-independent and results in selective accumulation of Aβ(1–42) compared to Aβ(1–40)
Wesén, E. V., Jeffries, G. D. M., Dzebo, M. M., & Esbjörner, E. K. (2017) · Scientific Reports · doi:10.1038/s41598-017-02227-9 · Cited by 115
Neuropathology and emerging biomarkers in corticobasal syndrome
Koga, S., Josephs, K. A., Aiba, I., Yoshida, M., & Dickson, D. W. (2022) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2021-328586 · Cited by 115
Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease?
Götz, J., Ittner, L. M., & Kins, S. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03955.x · Cited by 119
Omega-3 Fatty Acid Docosahexaenoic Acid Increases SorLA/LR11, a Sorting Protein with Reduced Expression in Sporadic Alzheimer's Disease (AD): Relevance to AD Prevention
Ma, Q., Teter, B., Ubeda, O. J., Morihara, T., Dhoot, D. S., Nyby, M. D., Tuck, M. L., Frautschy, S. A., & Cole, G. M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3593-07.2007 · Cited by 115
Synaptic Transmission and Hippocampal Long-Term Potentiation in Transgenic Mice Expressing FAD-Linked Presenilin 1
Parent, A., Linden, D. J., Sisodia, S. S., & Borchelt, D. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0207 · Cited by 116
Fine Mapping of the Chromosome 12 Late-Onset Alzheimer Disease Locus: Potential Genetic and Phenotypic Heterogeneity
Scott, W. K., Grubber, J. M., Conneally, P. M., Small, G. W., Hulette, C. M., Rosenberg, C. K., Saunders, A. M., Roses, A. D., Haines, J. L., & Pericak‐Vance, M. A. (2000) · The American Journal of Human Genetics · doi:10.1086/302828 · Cited by 114
Self-citation
Alzheimer's Disease, β-Amyloid Protein and Zinc
Huang, X., Cuajungco, M. P., Atwood, C., Moir, R. D., Tanzi, R. E., & Bush, A. I. (2000) · Journal of Nutrition · doi:10.1093/jn/130.5.1488s · Cited by 114
Self-citation
Characterization of the AD7C-NTP cDNA expression in Alzheimer's disease and measurement of a 41-kD protein in cerebrospinal fluid.
de la Monte, S. M., Ghanbari, K., Frey, W. H., Beheshti, I., Averback, P., Hauser, S. L., Ghanbari, H. A., & Wands, J. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119864 · Cited by 114
Autophagy in inflammation, infection, neurodegeneration and cancer
Arroyo, D. S., Gaviglio, E. A., Ramos, J. M. P., Bussi, C., Rodriguez‐Galán, M. C., & Iribarren, P. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.11.001 · Cited by 114
Defective Transcytosis of APP and Lipoproteins in Human iPSC-Derived Neurons with Familial Alzheimer’s Disease Mutations
Woodruff, G., Reyna, S. M., Dunlap, M., Van Der Kant, R., Callender, J. A., Young, J. E., Roberts, E. A., & Goldstein, L. S. B. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.034 · Cited by 105
Alzheimer’s Disease: Etiology, Neuropathology and Pathogenesis
Sheppard, O., & Coleman, M. P. (2020) · Exon Publications eBooks · doi:10.36255/exonpublications.alzheimersdisease.2020.ch1 · Cited by 127
Altered synaptic function in Alzheimer's disease
Bell, K. F. S., & Cuello, A. C. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.045 · Cited by 117
Expression of V642 APP mutant causes cellular apoptosis as Alzheimer trait‐linked phenotype.
Yamatsuji, T., Okamoto, T., Takeda, S., Murayama, Y., Tanaka, N., & Nishimoto, I. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00382.x · Cited by 113
Signaling crossroads: The function of Raf kinase inhibitory protein in cancer, the central nervous system and reproduction
Kłysik, J., Theroux, S. J., Sedivy, J. M., Moffit, J. S., & Boekelheide, K. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.07.003 · Cited by 112
The Genetics of Alzheimer’s Disease
Barber, R. C. (2012) · Scientifica · doi:10.6064/2012/246210 · Cited by 122
Overexpression of Wild Type But Not an FAD Mutant Presenilin-1 Promotes Neurogenesis in the Hippocampus of Adult Mice
Wen, P. H., Shao, X., Shao, Z., Hof, P. R., Wısnıewskı, T., Kelley, K. A., Friedrich, V. L., Ho, L., Pasinetti, G. M., Shioi, J., et al. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0490 · Cited by 111
Phosphorylation of presenilin-2 regulates its cleavage by caspases and retards progression of apoptosis
Walter, J., Schindzielorz, A., Grünberg, J., & Haass, C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1391 · Cited by 112
A lzheimer's disease and chronic periodontitis: Is there an association?
Gaur, S., & Agnihotri, R. (2014) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12425 · Cited by 116
A critical analysis of the ‘amyloid cascade hypothesis’
A. Armstrong, R. (2014) · Folia Neuropathologica · doi:10.5114/fn.2014.45562 · Cited by 110
Cannabinoids and the Brain
Köfalvi, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3 · Cited by 110
Local ancestry at APOE modifies Alzheimer's disease risk in Caribbean Hispanics
Blue, E., Horimoto, A. R. V. R., Mukherjee, S., Wijsman, E. M., & Thornton, T. A. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.07.016 · Cited by 113
The Toll→NFκB Signaling Pathway Mediates the Neuropathological Effects of the Human Alzheimer's Aβ42 Polypeptide in Drosophila
Tan, L., Schedl, P. D., Song, H., Garza, D., & Konsolaki, M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003966 · Cited by 112
The hemochromatosis gene affects the age of onset of sporadic Alzheimer’s disease
Sampietro, M., Caputo, L., Casatta, A., Meregalli, M., Pellagatti, A., Tagliabue, J., Annoni, G., & Vergani, C. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00219-6 · Cited by 111
Management of Alzheimer's Disease
Grossberg, G. T., & Desai, A. K. (2003) · The Journals of Gerontology Series A · doi:10.1093/gerona/58.4.m331 · Cited by 110
Neuroprotective Effects and Therapeutic Potential of the Citrus Flavonoid Hesperetin in Neurodegenerative Diseases
Evans, J. A., Mendonca, P., & Soliman, K. F. A. (2022) · Nutrients · doi:10.3390/nu14112228 · Cited by 111
Fatty acids, lipid metabolism and Alzheimer pathology
Hooijmans, C. R., & Kiliaan, A. J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.081 · Cited by 115
The Pathogenesis of Alzheimer′s Disease: A Reevaluation of the “Amyloid Cascade Hypothesis”
Armstrong, R. A. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/630865 · Cited by 117
Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease)
Roses, A. D., Saunders, A. M., Huang, Y., Strum, J. C., Weisgraber, K. H., & Mahley, R. W. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500397 · Cited by 109
Self-citation
The role of ABCB1 and ABCA1 in beta-amyloid clearance at the neurovascular unit in Alzheimer's disease
ElAli, A., & Rivest, S. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00045 · Cited by 115
Up-Regulation of Calcineurin Aβ mRNA in the Alzheimer's Disease Brain: Assessment by cDNA Microarray
Hata, R., Masumura, M., Akatsu, H., Li, F., Fujita, H., Nagai, Y., Yamamoto, T., Okada, H., Kosaka, K., Sakanaka, M., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4968 · Cited by 109
Familial Alzheimer's chromosome 14 mutations
Wasco, W., Pettingell, W. P., Jondro, P. D., Schmidt, S. D., Gurubhagavatula, S., Rodes, L., Di-Blasi, T., Romano, D., Guénette, S. Y., Kovacs, D. M., et al. (1995) · Nature Medicine · doi:10.1038/nm0995-848a · Cited by 109
Self-citation
Preimplantation Diagnosis for Early-Onset Alzheimer Disease Caused by V717L Mutation
Verlinsky, Y. (2002) · JAMA · doi:10.1001/jama.287.8.1018 · Cited by 109
A Reductionist View of Alzheimer's Disease
Lansbury, P. T. (1996) · Accounts of Chemical Research · doi:10.1021/ar950159u · Cited by 109
Amyloid‐β protein (Aβ) Glu11 is the major β‐secretase site of β‐site amyloid‐β precursor protein‐cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis
Deng, Y., Wang, Z., Wang, R., Zhang, X., Zhang, S., Wu, Y., Staufenbiel, M., Cai, F., & Song, W. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12235 · Cited by 108
Oxidative Stress in Alzheimer’s Disease: Should We Keep Trying Antioxidant Therapies?
Ferreira, M. E. S., de Vasconcelos, A. S., Vilhena, T. D. C., da Silva, T. L., Barbosa, A. D. S., Gomes, A. R. Q., Dolabela, M. F., & Percário, S. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0157-y · Cited by 112
Cellular Regulation of Amyloid Formation in Aging and Disease
Stroo, E., Koopman, M., Nollen, E. A. A., & Mata‐Cabana, A. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00064 · Cited by 119
What Can We Learn About Human Disease from the Nematode C. elegans?
Apfeld, J., & Alper, S. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7471-9_4 · Cited by 116
Presenilin-1 Mutations Reduce Cytoskeletal Association, Deregulate Neurite Growth, and Potentiate Neuronal Dystrophy and Tau Phosphorylation
Pigino, G. F., Pelsman, A., Mori, H., & Busciglio, J. A. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-03-00834.2001 · Cited by 109
Transcriptional regulation of APH‐1A and increased γ‐secretase cleavage of APP and Notch by HIF‐1 and hypoxia
Wang, R., Zhang, Y., Zhang, X., Liu, R., Zhang, X., Hong, S., Xia, K., Xia, J., Zhang, Z., & Xu, H. (2006) · The FASEB Journal · doi:10.1096/fj.06-5839fje · Cited by 112
Functional γ-secretase complex assembly in Golgi/trans-Golgi network: interactions among presenilin, nicastrin, Aph1, Pen-2, and γ-secretase substrates
Baulac, S., LaVoie, M. J., Kimberly, W. T., Strahle, J. M., Wolfe, M. S., Selkoe, D. J., & Xia, W. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00123-2 · Cited by 111
Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer’s disease
Bussière, T., Friend, P. D., Sadeghi, N., Wicinski, B. A., Lin, G. I., Bouras, C., Giannakopoulos, P., Robakis, N. K. R. K., Morrison, J. H., Perl, D. P., et al. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00056-8 · Cited by 108
Genes, models and Alzheimer's disease
Chapman, P. F., Falinska, A. M., Knevett, S. G., & Ramsay, M. F. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(01)02285-5 · Cited by 108
Alzheimer Aβ neurotoxicity: Promotion by antichymotrypsin, ApoE4; inhibition by Aβ-related peptides
Ma, J., Brewer, H. B., & Potter, H. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00112-1 · Cited by 108
Synaptic Dysfunction in Alzheimer’s Disease
Marcello, E. E., Epis, R., Saraceno, C., & Luca, M. D. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-3-7091-0932-8_25 · Cited by 115

Authors: Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J.-F., Bruni, A. C., Montesi, M. P., Sorbi, S., Rainero, I., Pinessi, L., Nee, L., Chumakov, I., Pollen, D., Brookes, A., Sanseau, P., Polinsky, R. J., Wasco, W., Da Silva, H. A. R., Haines, J. L., Pericak-Vance, M. A., Tanzi, R. E., Roses, A. D., Fraser, P. E., Rommens, J. M., & St George-Hyslop, P. H.
Affiliations: University of Toronto (CA)
Inserm (FR)
University of Florence (IT)
University of Turin (IT)
National Institutes of Health (US)
Fondation Jean Dausset-CEPH (FR)
University of Massachusetts Chan Medical School (US)
Western General Hospital (GB)
Sandoz Group AG (Switzerland) (CH)
Harvard University (US)
Duke University (US)
ORCID: Rogaev, E. I.
Liang, Y.
Rogaeva, E. A.
Ikeda, M.
Lin, C.
Tsuda, T.
Bruni, A. C.
Sorbi, S.
Rainero, I.
Pinessi, L.
Brookes, A.
Haines, J. L.
Tanzi, R. E.
Rommens, J. M.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 1995-06
Volume: 375
Issue: 6534
Pages: 754-760
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/375754a0
OpenAlex: W2046209489
Cited by: 4,051
References: 48
Citations by year: 2026: 36 · 2025: 70 · 2024: 78 · 2023: 54 · 2022: 93 · 2021: 93 · 2020: 118 · 2019: 107 · 2018: 105 · 2017: 116 · 2016: 140 · 2015: 100 · 2014: 132 · 2013: 120 · 2012: 134
FWCI: 144.01
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Florence Research (University of Florence) (submittedVersion)
Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
Funders: Canadian Institutes of Health Research (64309)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: early-onset familial Alzheimer's disease, missense mutations, autosomal dominant inheritance, gene cloning, co-segregation, transmembrane proteins, novel genes, susceptibility genes
MeSH terms: Alzheimer Disease, Amino Acid Sequence, Animals, Base Sequence, Chromosome Mapping, Chromosomes, Human, Pair 14, Cloning, Molecular, Female, Humans, Male, Membrane Proteins, Molecular Sequence Data, Mutation, Pedigree, Transcription, Genetic, Open Reading Frames, Protein Structure, Secondary, Mice, Presenilin-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks